Antioxidant pill tested to ease breathing in obese asthma patients
NCT ID NCT04026711
Summary
This small, early-stage study tested whether a daily antioxidant pill called MitoQ could improve breathing problems in adults with both obesity and poorly controlled asthma. Over 14 weeks, 40 participants took either MitoQ or a placebo pill. The main goal was to see if MitoQ reduced airway sensitivity and improved asthma symptoms and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University
Durham, North Carolina, 27710, United States
-
University of Vermont
Burlington, Vermont, 05405, United States
Conditions
Explore the condition pages connected to this study.